CALLOS ANDREW (Chief Commercial Officer) sold 19.3% of their position (14K shares) of CYTOKINETICS INC on the open market
Open‑market sale worth $1.12M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 7/30/2026ACC: 0001061983-26-000086
Officer· Chief Commercial Officer
Since Mar 2021
-14K
Net shares
Net seller
$1.12M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
14K acquired · 28K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+14K
Price / share
$23.26
Trade value
$325.64K
% of position
23.9%
7/30/2026
58.55K→72.56K
Common Stock
Direct
Shares
−14K
Price / share
$79.88
Trade value
$1.12M
% of position
19.3%
7/30/2026
72.56K→58.55K
Total
Net shares
+0.00
Net value
-$792.68K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/30/2026 | M · Option Exercise | +14K | $23.26 | $325.64K | 23.9% | 58.55K | 72.56K |
| Common Stock Direct | 7/30/2026 | S · Sale | −14K | $79.88 | $1.12M | 19.3% | 72.56K | 58.55K |
| Total | +0.00 | -$792.68K | ||||||
Derivative Transactions1
Non-Qualified Stock Option (Right to Buy)
Direct
Converts to
Common Stock
14K shares
Shares
−14K
Strike price
23.26
Held after
10K
Exercisable
—
7/30/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (Right to Buy) Direct | Common Stock14K shares | 7/30/2026 | M · Option Exercise | −14K | 23.26 | — | 10K |